155 related articles for article (PubMed ID: 34443600)
1. Tributyltin(IV) Butyrate: A Novel Epigenetic Modifier with ER Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells.
Giuliano M; Pellerito C; Celesia A; Fiore T; Emanuele S
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443600
[TBL] [Abstract][Full Text] [Related]
2. ROS-Dependent ER Stress and Autophagy Mediate the Anti-Tumor Effects of Tributyltin (IV) Ferulate in Colon Cancer Cells.
Celesia A; Morana O; Fiore T; Pellerito C; D'Anneo A; Lauricella M; Carlisi D; De Blasio A; Calvaruso G; Giuliano M; Emanuele S
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143349
[TBL] [Abstract][Full Text] [Related]
3. Tributyltin(IV) ferulate, a novel synthetic ferulic acid derivative, induces autophagic cell death in colon cancer cells: From chemical synthesis to biochemical effects.
Pellerito C; Emanuele S; Ferrante F; Celesia A; Giuliano M; Fiore T
J Inorg Biochem; 2020 Apr; 205():110999. PubMed ID: 31986423
[TBL] [Abstract][Full Text] [Related]
4. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
5. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
[TBL] [Abstract][Full Text] [Related]
6. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes.
Rada-Iglesias A; Enroth S; Ameur A; Koch CM; Clelland GK; Respuela-Alonso P; Wilcox S; Dovey OM; Ellis PD; Langford CF; Dunham I; Komorowski J; Wadelius C
Genome Res; 2007 Jun; 17(6):708-19. PubMed ID: 17567991
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, chemical characterization and biological activity of new histone acetylation/deacetylation specific inhibitors: a novel and potential approach to cancer therapy.
Pellerito O; Prinzivalli C; Foresti E; Sabatino P; Abbate M; Casella G; Fiore T; Scopelliti M; Pellerito C; Giuliano M; Grasso G; Pellerito L
J Inorg Biochem; 2013 Aug; 125():16-25. PubMed ID: 23685346
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
McBain JA; Eastman A; Nobel CS; Mueller GC
Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.
Saldanha SN; Kala R; Tollefsbol TO
Exp Cell Res; 2014 May; 324(1):40-53. PubMed ID: 24518414
[TBL] [Abstract][Full Text] [Related]
11. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
[TBL] [Abstract][Full Text] [Related]
12. Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells.
Silva LG; Ferguson BS; Avila AS; Faciola AP
J Anim Sci; 2018 Dec; 96(12):5244-5252. PubMed ID: 30252114
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
Ramaiah MJ; Tangutur AD; Manyam RR
Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and evaluation of Cd[L-proline]
Chidambaram A; Sekar A; S H K; Chidambaram RK; Arunachalam K; G P S; Vilwanathan R
Invest New Drugs; 2017 Dec; 35(6):691-705. PubMed ID: 28776290
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
[TBL] [Abstract][Full Text] [Related]
16. Effects of histone deacetylase inhibitor sodium butyrate on heroin seeking behavior in the nucleus accumbens in rats.
Chen WS; Xu WJ; Zhu HQ; Gao L; Lai MJ; Zhang FQ; Zhou WH; Liu HF
Brain Res; 2016 Dec; 1652():151-157. PubMed ID: 27742468
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis for histone acetylation of human colon cancer cells treated with a novel HDAC inhibitor.
Zhao Y; Fang X; Wang Y; Zhang J; Jiang S; Liu Z; Ma Z; Xu L; Li E; Zhang K
Curr Pharm Des; 2014; 20(11):1866-73. PubMed ID: 23888955
[TBL] [Abstract][Full Text] [Related]
18. Butyrate Stimulates Histone H3 Acetylation, 8-Isoprostane Production, RANKL Expression, and Regulated Osteoprotegerin Expression/Secretion in MG-63 Osteoblastic Cells.
Chang MC; Chen YJ; Lian YC; Chang BE; Huang CC; Huang WL; Pan YH; Jeng JH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562925
[TBL] [Abstract][Full Text] [Related]
19. Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities.
Dedes KJ; Dedes I; Imesch P; von Bueren AO; Fink D; Fedier A
Anticancer Drugs; 2009 Jun; 20(5):321-33. PubMed ID: 19322073
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of forskolin and dibutyryl cyclic AMP in neuroblastoma cells: evidence that some of the actions of dibutyryl cyclic AMP are mediated by butyrate.
Yusta B; Ortiz-Caro J; Pascual A; Aranda A
J Neurochem; 1988 Dec; 51(6):1808-18. PubMed ID: 2846786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
